Provesicles as Novel Drug Delivery Systems

被引:15
|
作者
Bayindir, Zerrin S. [1 ]
Yuksel, Nilufer [1 ]
机构
[1] Ankara Univ, Fac Pharm, Dept Pharmaceut Technol, TR-06100 Ankara, Turkey
关键词
Administration routes; characterization; provesicles; proliposomes; proniosomes; vesicular systems; IN-VIVO EVALUATION; ENHANCED INTESTINAL-ABSORPTION; MALTODEXTRIN-BASED PRONIOSOMES; NONIONIC SURFACTANT VESICLES; LOADED NEUTRAL PROLIPOSOMES; IMPROVED ORAL DELIVERY; VITRO SKIN PERMEATION; TRANSDERMAL DELIVERY; CANCER-THERAPY; BIOAVAILABILITY ENHANCEMENT;
D O I
10.2174/1389201016666150206101443
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vesicular systems exhibit many attractive properties such as controlled drug release, ability to carry both hydrophilic and hydrophobic drugs, targetability and good biocompatibility. With these unique properties they can provide improved drug bioavailability and reduced side effects. Until now, many vesicular formulations have been studied in clinical and preclinical stages. Nevertheless, the major concern about these systems is their low physicochemical stability and high manufacturing expenses. The stability problems (fusion, aggregation, sedimentation, swelling, and drug leakage during storage) associated with the aqueous nature of vesicular systems hinders their effective usage. The advances on improving the stability of vesicular systems led to the emergence of provesicular systems, which are commonly described as dry, free flowing pre-formulations of vesicular drug delivery systems. Provesicles form vesicular systems upon hydratation with water and exhibit the advantages of vesicular systems with improved stability. The present article briefly reviews vesicular systems (particularly liposomes and niosomes) and enlightens about the innovations in the field. Overall investigations are reviewed and the provesicle approach is explained by giving detailed information on the composition, preparation, administration and characterization methods of provesicular systems (proliposomes and proniosomes). The scope of this article is expected to give insight to the researchers and industrialists to perform further research in this area.
引用
收藏
页码:344 / 364
页数:21
相关论文
共 50 条
  • [1] Novel drug delivery systems
    Leland Lou
    Current Review of Pain, 1999, 3 (5): : 411 - 416
  • [2] NOVEL DRUG DELIVERY SYSTEMS
    VANBRUNT, J
    BIO-TECHNOLOGY, 1989, 7 (02): : 127 - 130
  • [3] NOVEL DRUG DELIVERY SYSTEMS
    LANGER, R
    CHEMISTRY IN BRITAIN, 1990, 26 (03) : 232 - &
  • [4] DRUG REGULATION AND NOVEL DRUG DELIVERY SYSTEMS
    SKELLY, JP
    NOVEL DRUG DELIVERY AND ITS THERAPEUTIC APPLICATION, 1989, : 341 - 351
  • [5] Novel Drug Delivery Systems for Phytomedicines
    Zhang, Xingwang
    Wu, Wei
    PHARMACEUTICS, 2024, 16 (08)
  • [6] Limitations to the Novel Drug Delivery Systems
    Gulnaaz, Syeda Asma
    Nadeem, Mohd Naseeruddin
    Chandrakala, Purna
    Mathur, Shobhna
    INDIAN JOURNAL OF PHARMACOLOGY, 2013, 45 : S128 - S128
  • [7] Novel colloidal drug delivery systems
    Westesen, K
    Bunjes, H
    Hammer, G
    Siekmann, B
    PDA JOURNAL OF PHARMACEUTICAL SCIENCE AND TECHNOLOGY, 2001, 55 (04) : 240 - 247
  • [8] Novel drug delivery systems for glaucoma
    Lavik, E.
    Kuehn, M. H.
    Kwon, Y. H.
    EYE, 2011, 25 (05) : 578 - 586
  • [9] NOVEL DRUG DELIVERY SYSTEMS: AN OVERVIEW
    Bhagwat, R. R.
    Vaidhya, I. S.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2013, 4 (03): : 970 - 982
  • [10] Novel drug delivery systems for glaucoma
    E Lavik
    M H Kuehn
    Y H Kwon
    Eye, 2011, 25 : 578 - 586